Suppr超能文献

鳞状和非鳞状非小细胞肺癌组织学鉴别中观察者间变异性的系统评价。

A systematic review of the interobserver variability for histology in the differentiation between squamous and nonsquamous non-small cell lung cancer.

机构信息

Health Technology Analysts Pty Ltd, NSCCHS Cancer Trials Network-Royal North Shore Hospital, Sydney, Australia.

出版信息

J Thorac Oncol. 2011 Jan;6(1):55-63. doi: 10.1097/JTO.0b013e3181fc0878.

Abstract

INTRODUCTION

The importance of identifying non-small cell lung cancer (NSCLC) histologic subtype has increased recently because of the development of target-specific chemotherapeutic agents. This systematic review was undertaken to examine the interobserver variability for histology in differentiating between subtypes of NSCLC, specifically the ability to differentiate squamous from nonsquamous histology.

METHODS

A systematic literature search was undertaken to identify studies that evaluated the reproducibility of histologic diagnosis by pathologists in their reporting of NSCLC subtypes. Studies were screened using a priori defined eligibility criteria. The National Health and Medical Research Council diagnostic levels of evidence were applied and quality assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Data were extracted and reanalyzed to permit comparison of agreement in nonsquamous and squamous cell carcinoma by 2 × 2 tables. Percentage agreement and kappa statistics were calculated for each included study.

RESULTS

Out of 1480 articles identified through the literature search, six were eligible for inclusion. The percentage agreement for all subtypes of NSCLC in the included studies ranged from 67.1 to 89.6% (κ, 0.42-0.84). Based on the primary reanalysis of data (reanalysis 1), agreement between pathologists in differentiating nonsquamous and squamous histology ranged from 77.0 to 94.2% (κ = 0.48-0.88) indicating a moderate to high level of agreement.

CONCLUSION

The reasonably high agreement and kappa statistics for the included studies suggest that pathologists can reproducibly differentiate between nonsquamous and squamous NSCLC. This is clinically important in guiding oncologist decision making in choosing the most appropriate therapy for their patients.

摘要

简介

由于靶向特异性化疗药物的发展,识别非小细胞肺癌(NSCLC)组织学亚型的重要性日益增加。进行这项系统评价是为了检查组织学在区分 NSCLC 亚型方面的观察者间变异性,特别是区分鳞状和非鳞状组织学的能力。

方法

系统地检索文献,以确定评估病理学家在报告 NSCLC 亚型时组织学诊断可重复性的研究。使用预先定义的合格标准筛选研究。应用澳大利亚和新西兰卫生保健标准委员会诊断证据水平,并使用诊断准确性研究质量评估工具进行质量评估。提取数据并重新分析,以允许通过 2×2 表比较非鳞状细胞癌和鳞状细胞癌的一致性。计算每个纳入研究的总符合率和 Kappa 统计量。

结果

通过文献检索共确定了 1480 篇文章,其中 6 篇符合纳入标准。纳入研究中所有 NSCLC 亚型的总符合率范围为 67.1%至 89.6%(κ 值为 0.42 至 0.84)。基于对数据的主要重新分析(重新分析 1),病理学家在区分非鳞状和鳞状组织学方面的一致性范围为 77.0%至 94.2%(κ=0.48 至 0.88),表明一致性处于中等至高水平。

结论

纳入研究的一致性和 Kappa 统计量相当高,这表明病理学家可以可靠地区分非鳞状和鳞状 NSCLC。这在指导肿瘤学家在为患者选择最合适的治疗方案方面具有重要的临床意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验